2026 Nobel Chemistry Prize honors research on chiral molecules with implications for drug development

Henri B. Kagan, 95, and Kenso Soai, 76, received the 2026 Nobel Prize in chemistry for their work on asymmetric organic synthesis.

Their research uncovered how certain reactions can act as their own catalyst, preferentially producing one mirror‑image form of a molecule-a phenomenon known as chirality that underlies many biological processes.

The Nobel Committee highlighted the discovery of non‑linear effects and autocatalysis as a breakthrough that could influence how new pharmaceuticals are designed and manufactured.

The award underscores the relevance of fundamental chemistry to future drug development and highlights the long‑standing curiosity about why living systems contain only one version of chiral compounds.